Lupin (LUPIN) — Financial Results

1 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Lupin Limited reported Q2 FY2026 revenue of ₹68,314 million, growing 24.3% YoY and 10.8% QoQ. Net profit surged 72.8% YoY to ₹14,848 million, while EBITDA jumped 75.8% YoY to ₹24,313 million with margin expansion of 1,040 bps to 35.6%. U.S. sales grew 47.3% YoY to ₹27,624 million (40% of global sales), with 6 new ANDA approvals and 147 generic products in market. India sales grew 3.4% YoY to ₹20,777 million. Emerging markets surged 45.3% YoY.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Lupin Limited reported Q2 FY26 net sales of ₹68,314 million, up 24.3% YoY, with net income reaching ₹14,779 million, a 73.3% YoY increase. EBITDA margin expanded to 31.3% from 23.8% YoY, driven by strong US performance (46% YoY growth) and LATAM momentum (81% YoY growth). India business grew modestly at 3% YoY. The company achieved highest US quarterly sales since Q3 FY17 through successful launches of Glucagon and Liraglutide injectables, while maintaining regulatory compliance across multiple sites.

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 6 November 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 6 November 2025

SBIN State Bank of India Offer Document SBIN State Bank of India Offer Document SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results UNIONBANK Union Bank of India Financial Results WIPRO Wipro Limited Corporate Action SBIN State Bank of India Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.